NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Eli Lilly and Company
University Hospital, Lille
Revolution Medicines, Inc.
Eli Lilly and Company
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Turning Point Therapeutics, Inc.
Hoffmann-La Roche
Revolution Medicines, Inc.